STC2 and Stroke: We found that administration of STC2 leads to an improvement in functional recovery (Fig. 5b, Supplementary Figs. 19 and 20) and to an increase in endogenous neuroblasts migrating toward the peri-infarct region (BrdU, with Doublecortin at 6 weeks post-stroke, Fig. 5c).